ArticleFrontiers in oncology2023

Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review.

Yingmei Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.